The Astarte team is proud to support scientists around the world in pursuing their research goals, and we get excited every time a customer’s work is published.
2018 was a great year for us and our customers. Review some of the amazing journal articles and patent applications that came out over the past year using Astarte immune cells and reagents.
Congratulations to our customers on all of their hard work!
Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release. Journal of Controlled Release. 2018.
Monocyte function in patients with myelodysplastic syndrome. Journal of Leukocyte Biology. 2018.
Antigen-Specific T Cells
Generation and analysis of human T cell lines responsive to Glatiramer Acetate. Cell Reports. 2018.
CD3+ T Cells
Automated expansion of primary human T cells in scalable and cell‐friendly hydrogel microtubes for adoptive immunotherapy. Advanced Healthcare Materials. 2018.
An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides. Journal for ImmunoTherapy of Cancer. 2018.
BC3 T Cell Lines
Supplementation of specific carbohydrates results in enhanced deposition of chondrogenic-specific matrix during mesenchymal stem cell differentiation. Journal of Tissue Engineering and Regenerative Medicine. 2018.
Botulinum toxin blocks mast cells and prevents rosacea like inflammation. Journal of Dermatological Science. 2018.